logo

QNTM

Quantum BioPharma·NASDAQ
--
--(--)
--
--(--)

QNTM fundamentals

Quantum BioPharma (QNTM) expects to report earnings on Mar 24, 2026, with estimated revenue of 0 (YoY --), and EPS at -1.0215 (YoY +63.23%).
Revenue estimate / YoY
0
--
EPS estimate / YoY
-1.0215
+63.23%
Report date
Mar 24, 2026

Earnings

EPS
Revenue

Revenue & Expenses

Key Indicators

Quantum BioPharma (QNTM) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Quantum BioPharma (QNTM)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

Quantum BioPharma (QNTM)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

Quantum BioPharma (QNTM)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does Quantum BioPharma (QNTM) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track Quantum BioPharma (QNTM) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield